What is one effect of rapid diagnostics on the antimicrobial stewardship pharmacist's role?

• A. Rapid diagnostics can dramatically reduce the time to pathogen identification.
• B. Rapid diagnostics have no impact on patient care.
• C. Rapid diagnostics extend the time to pathogen identification.
• D. Rapid diagnostics eliminate the need for pharmacists.

Answer: (A)

Rapid diagnostics speed up the process of identifying the causative organism, often delivering results in hours instead of days. This accelerates the antimicrobial stewardship pharmacist’s ability to tailor therapy sooner—moving from broad-spectrum empiric regimens to targeted, narrow-spectrum agents, optimizing dosing, and shortening the duration of therapy. The pharmacist interprets the rapid results, communicates changes to the care team, and coordinates de-escalation and optimization, which can improve patient outcomes and reduce antimicrobial exposure. For example, technologies like MALDI-TOF give rapid organism ID, while multiplex PCR panels can reveal resistance markers, enabling earlier, informed decisions. Rapid diagnostics therefore enhance the pharmacist’s role in stewardship, rather than eliminating it or delaying therapy.